Condition
Nasal Septum; Deviation, Congenital
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06434675CompletedPrimary
Prevalence of Variants of Nasal Cavity and Nasal Septum in Nepalese
NCT05243147Not ApplicableCompletedPrimary
Design and Application of Nasal Stents
NCT04891263Not ApplicableTerminatedPrimary
Suture-based, Minimally Invasive Technique Used to Correct NSD
NCT03976609CompletedPrimary
Three Dimensional Changes on Nasal Septum and Alveolar Cleft After Maxillary Expansion
Showing all 4 trials